Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Videos
Specialized Packaging
Healthcare Products
Return to: PKBR Home | Specialized Packaging | Healthcare Products

PCI completes acquisition of Pharmaceutical Packaging Professionals

PKBR Staff Writer Published 02 March 2018

PCI Pharma Services has completed the acquisition of Melbourne, Australia-based Pharmaceutical Packaging Professionals (PPP).

PPP is a provider of clinical trial manufacturing, packaging, storage and distribution services.

The acquisition allows PCI to offer an earlier stage outsourcing services to its clients in conducting trials in the region. PCI plans to establish PPP’s Melbourne, Victoria offices as its regional headquarters for Asia Pacific.

PCI says that Australia is a preferred destination to conduct phase 1 clinical studies and with this acquisition, it will provide new services in early phase clinical sterile and non-sterile drug manufacture along with the establishment of a PCI depot to serve the Asia Pacific market.

PPP’s logistical services include storage capability across a range of temperature conditions including Controlled Room Temperature 2-8°C, -20°C, and -80°C environments. This will expand PCI’s existing abilities in storing, packaging and shipping cold chain products.

With considerable growth in phase I study in Australia and Asia Pacific countries, PPP is presently is planning to expand its facility and upgrade its storage and distribution services, labeling and packaging rooms, Grade D manufacturing capabilities and sterile-fill manufacturing for Phase II clinical studies. 

PCI Pharma Services president and CEO Bill Mitchell said: “As a leading outsourced services partner, we look for ways to better support our customers in markets where they do business. 

"Asia Pacific, including Australia, has become an important region for clinical trials and we are focused on building upon PPP’s successes to continue to support our customers’ needs throughout the drug development lifecycle. 

“PCI is investing to be the partner of choice for our clients as they grow, evolve, and access new markets around the world.”

PPP is the fifth company that PCI has purchased in the past five years. Last year in October, PCI acquired Dublin-based Millmount Healthcare and has expanded its geographic presence in the European Union. The acquisition is expected to complement its service network in the UK.